Angiodynamics (ANGO) Consolidated Net Income (2010 - 2026)

Angiodynamics (ANGO) has 17 years of Consolidated Net Income data on file, last reported at -$11.4 million in Q2 2026.

• Quarterly Consolidated Net Income fell 88.51% year-over-year to -$11.4 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$36.7 million (down 8.09% YoY) and the FY2026 annual result came in at -$36.7 million, down 8.09% from the prior year.
• Consolidated Net Income slipped to -$11.4 million in Q2 2026, from -$8.1 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $45.9 million in Q3 2023 to a low of -$187.7 million in Q1 2024.
• A 5-year average of -$17.7 million and a median of -$10.1 million in 2023 frame the typical range for Consolidated Net Income.
• Annual changes were most pronounced in 2023 — Consolidated Net Income jumped 452.85% — and 2024, when it slumped 1879.29%.
• Tracing ANGO's Consolidated Net Income over 5 years: stood at -$8.5 million in 2022, then slumped by 242.3% to -$29.0 million in 2023, then jumped by 63.03% to -$10.7 million in 2024, then soared by 40.86% to -$6.4 million in 2025, then plunged by 79.61% to -$11.4 million in 2026.
• The last three Consolidated Net Income figures came in at -$11.4 million (Q2 2026), -$8.1 million (Q1 2026), and -$6.4 million (Q4 2025), per Business Quant data.